Almost all animal models for chronic rejection (CR) after lung transplantation (LTx) fail to resemble the human situation. It was our attempt to develop a representative model of CR in mice. Orthotopic LTx was performed in allografts receiving daily immunosuppression with steroids and cyclosporine. Controls included isografts and mice only undergoing thoracotomy (SHAM). Allografts were sacrificed 2, 4, 6, 8, 10 or 12 weeks after LTx. Pulmonary function was measured repeatedly in the 12w allografts, isografts and SHAM mice. Histologically, all allografts demonstrated acute rejection (AR) around the blood vessels and airways two weeks after LTx. This decreased to 50–75% up to 10 weeks and was absent after 12 weeks. Obliterative bronchiolitis (OB) lesions were observed in 25–50% of the mice from 4–12 weeks. Isografts and lungs of SHAM mice were normal after 12 weeks. Pulmonary function measurements showed a decline in FEV0.1, TLC and compliance in the allografts postoperatively (2 weeks) with a slow recovery over time. After this initial decline, lung function of allografts increased more than in isografts and SHAM mice indicating that pulmonary function measurement is not a good tool to diagnose CR in a mouse. We conclude that a true model for CR, with clear OB lesions in about one third of the animals, but without a decline in lung function, is possible. This model is an important step forward in the development of an ideal model for CR which will open new perspectives in unraveling CR pathogenesis and exploring new treatment options.
References
[1]
Sayegh M, Carpenter C (2004) Transplantation 50 years later–progress, challenges, and promises. N Engl J Med 351: 2761–6.
[2]
McDyer JF (2007) Human and murine obliterative bronchiolitis in transplant. Proc Am Thorac 1: 37–43.
[3]
Hele D, Yacoub M, Belvisi M (2001) The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Respir Res 2: 169–83.
[4]
Appel J, Lee S, Hartwig M, Li B, Hsieh C, et al. (2007) Characterization of the innate immune response to chronic aspiration in a novel rodent model. Respir Res 8: 87.
[5]
Svetlecic J, Molteni A, Herndon B (2004) Bronchiolitis obliterans induced by intratracheal papaverine: a novel animal model. Lung 182: 119–34.
[6]
Veith F, Richards K (1970) Improved technic for canine lung transplantation. Ann Surg 171: 553–8.
[7]
Hammainen P (1993) Single lung transplantation in piglets. Technique and follow-up. Scand J Thorac Cardiovasc Surg 27: 71–80.
[8]
Castaneda A, Arnar O, Schmidt-Habelman P, Moller JH, Zamora R (1972) Cardiopulmonary autotransplantation in primates. J Cardiovasc Surg (Torino) 13: 523–31.
[9]
Jungraithmayr W, Vogt P, Inci I, Hillinger S, Arni S, et al. (2010) A model of chronic lung allograft rejection in the rat. Eur Respir J 35: 1354–63.
[10]
Okazaki M, Krupnick AS, Kornfeld C, Lai J, Ritter J, et al. (2007) A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant 7: 1672–9.
[11]
Jungraithmayr W, Korom S, Hillinger S, Weder W (2009) A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg 137: 486–91.
[12]
Vessie E, Hirsch G, Lee T (2005) Aortic allograft vasculopathy is mediated by CD8(+) T cells in Cyclosporin A immunosuppressed mice. Transpl Immunol 15: 35–44.
[13]
De Vleeschauwer S, Rinaldi M, De Vooght V, Vanoirbeek J, Vanaudenaerde B, et al. (2011) Repeated invasive lung function measurements in intubated mice: an approach for longitudinal lung research. Lab Anim 45: 81–9.
[14]
Stewart S, Fishbein M, Snell G, Berry G, Boehler A, et al. (2007) Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26: 1229–42.
[15]
Gelman A, Okazaki M, Lai J, Kornfeld C, Kreisel F, et al. (2008) CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants. J Immunol 180: 4754–62.
[16]
Draenert A, Marquardt K, Inci I, Soltermann A, Weder W, et al. (2011) Ischaemia-reperfusion injury in orthotopic mouse lung transplants - a scanning electron microscopy study. Int J Exp Pathol 92: 18–25.
[17]
Jungraithmayr W, De Meester I, Matheeussen V, Inci I, Augustyns K, et al. (2010) Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic mouse lung transplants: the pivotal role of vasoactive intestinal peptide. Peptides 31: 585–91.
[18]
Fan L, Benson H, Vittal R, Mickler E, Presson R, et al. (2011) Neutralizing IL-17 Prevents Obliterative Bronchiolitis in Murine Orthotopic Lung Transplantation. Am J Transplant 11: 911–22.
[19]
Glanville A, Aboyoun C, Havryk A, Plit M, Rainer S, et al. (2008) Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med 177: 1033–40.
[20]
Okazaki M, Gelman A, Tietjens J, Ibricevic A, Kornfeld C, et al. (2007) Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol 37: 625–30.
[21]
Voswinckel R, Motejl V, Fehrenbach A, Wegmann M, Mehling T, et al. (2004) Characterisation of post-pneumonectomy lung growth in adult mice. Eur Respir J 24: 524–32.
[22]
Egan J (2004) Obliterative bronchiolitis after lung transplantation: a repetitive multiple injury airway disease. Am J Respir Crit Care Med 170: 931–2.
[23]
Estenne M, Maurer J, Boehler A, Egan J, Frost A, et al. (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21: 297–310.
